Technology
Health
Medical

Trinity Biotech

$2.83
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.06 (-2.12%) Today
-$0.06 (-2.12%) Today

Why Robinhood?

You can buy or sell TRIB and other stocks, options, ETFs, and crypto commission-free!

About

Trinity Biotech Plc engages in the development, manufacture, and marketing of medical diagnostic products for the clinical laboratory and point-of-care segments of the diagnostic market. It operates through the Americas and Rest of World geographical segment. Read More The company was founded by Ronan O'Caoimh and Denis R. Burger in June 1992 and is headquartered in Bray, Ireland.

Employees
556
Headquarters
Bray, Wicklow
Founded
1992
Market Cap
59.26M
Price-Earnings Ratio
19.24
Dividend Yield
0.00
Average Volume
50.89K
High Today
$2.93
Low Today
$2.83
Open Price
$2.88
Volume
5.65K
52 Week High
$6.00
52 Week Low
$2.13

Collections

Technology
Health
Medical
Advertising and Marketing
Business Services
Europe (Non-UK)
Europe

News

Seeking AlphaMar 12

Medical And Genetic Test Kits Sales Are Booming

Purchasing MTDKs is easy. Kits are sold in retail stores and online to consumers and physicians. Accessibility, insurance coverage, and reliability are key ingredients for success. They are rightly positioned to give the public information about their health status, propensities for illnesses, diseases, allergies, and ancestry. Credit the home pregnancy test for initiating the industry. Two companies I recommend to investors moving into the $30B MTDK industry are Exact Sciences and Myriad Genetics that ar...

1
MarketBeatMar 8

Stock Price, News, & Analysis for Trinity Biotech

Trinity Biotech plc acquires, develops, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market.

1
Seeking AlphaMar 7

Trinity Biotech PLC (TRIB) CEO Ronan O'Caoimh on Q4 2018 Results - Earnings Call Transcript

Trinity Biotech PLC (NASDAQ:TRIB) Q4 2018 Earnings Conference Call March 7, 2019 11:00 AM ET Company Participants Joe Diaz - Lytham Partners Kevin Tansley - CFO, Company Secretary & Executive Director Ronan O’Caoimh - Co-Founder, Chairman & CEO Conference Call Participants James Sidoti - Sidoti & Company Paul Nouri - Noble Equity Funds Operator Good day, and welcome to the Trinity Biotech Fourth Quarter and Fiscal Year 2018 Financial Results Conference Call. [Operator Instructions]. Please note, th...

6

Earnings

$0.04
$0.05
$0.06
$0.07
Q2 2017
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Estimated
$0.04 per share
Actual
$0.07 per share
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.